by agenda | Dec 7, 2017 | News
RICHMOND, VA Bright Path Pharmaceuticals, LLC (privately held), today announced that ChemWerth’s Chief Scientific Officer, Dr. Xiping Su, has joined the Board of the company following their investment in BPP. Xiping Su, Ph.D., is organic chemistry and...
by agenda | Aug 27, 2017 | News
CHARLOTTE, NC Bright Path Pharmaceuticals, LLC (privately held) today announced that Todd N. Smith, Chairman and CEO of Novum Pharma will join the Board. Mr. Smith has twenty-five years of pharmaceutical, medical device and biotechnology general management experience...